{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:29:51Z","timestamp":1787902191664,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273461"],"award-info":[{"award-number":["81273461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473150"],"award-info":[{"award-number":["81473150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2013CB932500"],"award-info":[{"award-number":["2013CB932500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jconrel.2014.07.050","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T11:55:00Z","timestamp":1407153300000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"192","author":[{"given":"Chi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-609X","authenticated-orcid":false,"given":"Zheming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.07.050_bb0005","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/cn400011f","article-title":"Abeta42-binding peptoids as amyloid aggregation inhibitors and detection ligands","volume":"4","author":"Luo","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2217\/nnm.11.114","article-title":"Therapeutic compliance of nanomedicine in Alzheimer's disease","volume":"6","author":"Wilson","year":"2011","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pneurobio.2011.11.008","article-title":"The future of Alzheimer's disease: the next 10years","volume":"95","author":"Hampel","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","article-title":"Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer's disease","volume":"108","author":"Roney","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/wnan.59","article-title":"Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease","volume":"2","author":"Kulkarni","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/ml300058m","article-title":"The \u03b2-amyloid hypothesis in Alzheimer's disease: seeing is believing","volume":"3","author":"Kung","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0040","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","article-title":"Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0055","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","article-title":"Targeting the brain with PEG\u2013PLGA nanoparticles modified with phage-displayed peptides","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/0-387-23226-5_18","article-title":"Amyloid inhibitors and beta-sheet breakers","volume":"38","author":"Soto","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lfs.2012.12.004","article-title":"Effects of beta-sheet breaker peptides on altered responses of thoracic aorta in rats' Alzheimer's disease model induced by intraamygdaloid Abeta40","volume":"92","author":"Bolukbasi","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0070","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.cellbi.2008.01.043","article-title":"Comparison of the inhibitory activities of the \u03b2-sheet breakers on \u03b2-amyloid protein","volume":"32","author":"He","year":"2008","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0075","first-page":"302","article-title":"Influence of H102 on the expression of amyloid protein and amyloid precursor protein in the hippocampus of APP695 transgenic mice","volume":"26","author":"Xu","year":"2010","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1023\/A:1011922819926","article-title":"Stealth PLA\u2013PEG nanoparticles as protein carriers for nasal administration","volume":"15","author":"Tobio","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/1061186X.2011.622396","article-title":"Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations","volume":"20","author":"Chen","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jps.2600820718","article-title":"Estimation of variance for AUC in animal studies","volume":"82","author":"Yuan","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0095","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1016\/j.biomaterials.2011.07.069","article-title":"A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein","volume":"32","author":"Huile","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0100","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1750-1326-6-85","article-title":"Adult hippocampal neurogenesis and its role in Alzheimer's disease","volume":"6","author":"Mu","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroimage.2011.01.062","article-title":"Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease","volume":"56","author":"Lotjonen","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2011.00019","article-title":"Interactions of AChE with Abeta aggregates in Alzheimer's brain: therapeutic relevance of IDN 5706","volume":"4","author":"Carvajal","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","article-title":"Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer's disease","volume":"122","author":"Shao","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","article-title":"Synaptic degeneration in Alzheimer's disease","volume":"118","author":"Arendt","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-2010-100948","article-title":"Amyloid-beta induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors","volume":"22","author":"Liu","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/dneu.22128","article-title":"The emerging role of SHANK genes in neuropsychiatric disorders","volume":"74","author":"Guilmatre","year":"2014","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7258(00)00081-4","article-title":"Animal models of Alzheimer's disease and evaluation of anti-dementia drugs","volume":"88","author":"Yamada","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tig.2006.03.007","article-title":"A decade of modeling Alzheimer's disease in transgenic mice","volume":"22","author":"McGowan","year":"2006","journal-title":"Trends Genet."},{"key":"10.1016\/j.jconrel.2014.07.050_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1389450043345236","article-title":"Posttranslational modifications of tau-role in human tauopathies and modeling in transgenic animals","volume":"5","author":"Chen","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2014.07.050_bb0170","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","article-title":"Drug discovery in dementia: the role of rodent models","volume":"5","author":"Van Dam","year":"2006","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914005446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914005446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:34:05Z","timestamp":1759160045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914005446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":34,"alternative-id":["S0168365914005446"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.07.050","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}